Psilocybin Therapy and the Rise of Existential Medicine
This article explains psilocybin therapy and the current research around its use in mental health care. It focuses on how clinical studies are structured, what participants can expect, and the possible benefits and limitations of treatment.
Provider
Details
Enrollment
Course Overview
Psilocybin Therapy and the Rise of Existential Medicine examines the renewed scientific interest in psilocybin after decades of limited research. The article draws on a conversation with Dr. Charles Grob to explain how psilocybin therapy is being studied for conditions such as substance use disorder, treatment-resistant depression, and other hard-to-treat psychological conditions. It also describes the typical structure of a psilocybin clinical trial, including screening, preparatory sessions, supervised dosing in a controlled setting, and the use of placebo-controlled, double-blind methods. The piece is intended for readers who want a clear overview of psilocybin-assisted psychotherapy and the practical realities of current research. The content is informational rather than instructional and reflects the legal and scientific limits of access to psilocybin therapy in most places.
Who is this for?
Readers interested in psilocybin therapy, psychedelic research, and the current scientific study of psychedelic-assisted psychotherapy.
About the Provider
Psychedelic media publication covering education, culture, policy, and practical guidance around psychedelic use and integration.
View Double Blind profileCourse Details
- PricePrice on request
- Lifecycle statusNo New Dates
- SkillsIntegrationFacilitationPsychotherapyPsilocybin TherapyMicrodosingEthicsMusic and Set/SettingUnderstanding psilocybin therapy researchRecognizing clinical trial structureInterpreting placebo-controlled study designLearning about preparatory and dosing sessionsReviewing therapeutic applications and limitationsInterpreting clinical trial structureReviewing mental health applications of psilocybin
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026
Accredited vs Non-Accredited Psychedelic Training
By AAA Learning Institute
Compare accredited and non-accredited psychedelic training programs, with an overview of what accreditation means and how to evaluate program quality. The page focuses on structure, practicum, curriculum, and practical considerations for prospective psilocybin facilitator students.
Aotearoa New Zealand Psilocybin Training
By Therapsil
A 106-hour live online training in psilocybin-assisted psychotherapy with an Aotearoa New Zealand-specific curriculum, delivered in partnership with PsyTrain. It is designed to support clinical practice with supervised learning and expert faculty input.
Dates not announced